Mattson J S, Gallagher S J, Jabro M H
Creighton University School of Dentistry, Department of Periodontology, Omaha, NE 68137, USA.
J Periodontol. 1999 May;70(5):510-7. doi: 10.1902/jop.1999.70.5.510.
The use of barrier membranes in the treatment of periodontal defects is well documented. There has been an increase in the use of bioabsorbable materials which do not require a second surgical procedure for removal. However, there are little data evaluating the efficacy of bioabsorbable membranes in the treatment of intrabony defects. The purpose of this investigation was to evaluate the regenerative potential of 2 bioabsorbable barrier membranes without the use of grafting materials in the treatment of interdental intrabony defects.
Twenty-three 2- or 3-walled intrabony defects were treated in 19 patients with a mean age of 50.4 years. All had completed nonsurgical treatment and a period of supportive periodontal therapy. The sites were randomly chosen to receive a barrier membrane composed of type I bovine collagen (11) or a copolymer of polylactic acid (PGA/PLA;12). A pressure sensitive disc probe was used to evaluate the following criteria at baseline and re-entry: 1) occlusal surface to the apical depth of probe penetration (OS-DP); 2) occlusal surface to the gingival margin (OS-GM); 3) occlusal surface to the alveolar crest (OS-AC); and 4) occlusal surface to the base of the osseous defect (OS-BD). Full thickness mucoperiosteal flaps were reflected to expose the surgical sites. The defects were debrided of the granulomatous tissue, the root surfaces instrumented and conditioned with 4 one-minute applications of 50 mg/ml of tetracycline. The barrier membranes were adapted to cover the defects and the flaps replaced. The postsurgical healing was uneventful and similar in both treatment modalities.
Twenty-three sites were surgically re-entered 6 months from the time of the initial surgery. The deepest probe depth for each site was used for statistical analysis. There was a mean relative attachment gain of 2.58+/-1.90 mm for the collagen, and 2.77+/-2.13 mm for the copolymer. There was a decrease in probing depth of 3.27+/-1.91 mm and 0.69+/-1.35 mm of recession for the collagen. The PGA/PLA copolymer had 3.55+/-2.47 mm reduction in probe depth and 0.78+/-1.14 mm of recession.
The data indicated the bioabsorbable collagen and copolymer membranes resulted in comparable results. A larger sample size would be necessary to determine if one membrane was superior to the other.
屏障膜在牙周缺损治疗中的应用已有充分文献记载。可生物吸收材料的使用有所增加,这类材料无需二次手术取出。然而,评估可生物吸收膜治疗骨内缺损疗效的数据较少。本研究的目的是在不使用移植材料的情况下,评估两种可生物吸收屏障膜治疗牙间骨内缺损的再生潜力。
对19例平均年龄50.4岁的患者的23个二壁或三壁骨内缺损进行治疗。所有患者均已完成非手术治疗及一段支持性牙周治疗。随机选择部位接受由I型牛胶原(11个部位)或聚乳酸共聚物(PGA/PLA;12个部位)组成的屏障膜。在基线和再次手术时,使用压力敏感盘式探针评估以下标准:1)探针从咬合面到根尖穿透深度(OS-DP);2)探针从咬合面到牙龈边缘的距离(OS-GM);3)探针从咬合面到牙槽嵴的距离(OS-AC);4)探针从咬合面到骨缺损底部的距离(OS-BD)。翻起全厚粘骨膜瓣以暴露手术部位。清除缺损处的肉芽组织,对牙根表面进行器械处理并用50mg/ml四环素处理4次,每次1分钟。将屏障膜贴合覆盖缺损处,然后复位瓣。两种治疗方式术后愈合均顺利且相似。
在初次手术6个月后对23个部位进行再次手术。每个部位的最深探针深度用于统计分析。胶原组平均相对附着增加2.58±1.90mm,共聚物组为2.77±2.13mm。胶原组探针深度减少3.27±1.91mm,牙龈退缩0.69±1.35mm。PGA/PLA共聚物组探针深度减少3.55±2.47mm,牙龈退缩0.78±1.14mm。
数据表明可生物吸收的胶原膜和共聚物膜产生了类似的结果。需要更大样本量来确定一种膜是否优于另一种膜。